Table 1 Baseline characteristics of the study population.

From: Serum Lipid Levels and Risk Of Hand Osteoarthritis: The Chingford Prospective Cohort Study

 

Final study population N = 277

Lost to follow-up (N = 306)

No serum lipid profile (N = 107)

N (%)

N (%)

N (%)

Age*

50.4 (4.8)

55.4 (6.1)

54.4 (4.7)

Any current education

81 (29.2)

141 (46.2)

41 (38.2)

Blood pressure medication

30 (10.8)

50 (16.3)

18 (16.8)

Diabetes medication

6 (2.1)

1 (0.3)

Statins

8 (2.9)

5 (14.7)

7 (6.5)

Previous CVD

3 (1.0)

18 (5.9)

1 (0.9)

Menopause

163 (58.8)

247 (80.9)

88 (82.2)

Age at menopause*

45.9 (5.7)

47.6 (5.1)

47.2 (4.9)

Previous HRT

70 (25.2)

79 (25.8)

27 (25.2)

Smoking

 Ex-smoker

62 (22.3)

75 (24.5)

29 (27.1)

 Current

69 (24.9)

79 (25.8)

18 (16.8)

Extent of activity in job

 Sedentary

11 (4.0)

12 (4.1)

13 (54.8)

 Half sedentary + half active

211 (77.0)

236 (78.9)

37 (25.6)

 Predominantly manual

52 (19.0)

51 (17.0)

10 (9.6)

Sport

 None

183 (66.7)

220 (73.3)

57 (54.8)

 Light

38 (13.8)

39 (13.0)

20 (19.2)

 Moderate

35 (12.7)

16 (5.3)

17 (16.3)

 Intensive

18 (6.8)

25 (8.4)

10 (9.6)

 Obesity

24 (8.6)

58 (18.9)

15 (14.0)

 BMI*

24.8 (3.9)

26.1 (5.0)

25.5 (3.8)

Blood pressure (mmHg)*

 Systolic

122.4 (19.9)

130.3 (20.1)

128.8 (15.2)

 Diastolic

76.4 (11.2)

79.6 (11.5)

78.1 (9.2)

 Glucose mmol/L*

4.9 (0.1)

5.0 (0.8)

 TG mmol/L*

1.1 (0.6)

1.2 (0.6)

 TC mmol/L*

6.3 (1.3)

6.7 (1.3)

 HDL-c mmol/L*

1.7 (0.4)

1.7 (0.4)

 LDL-c mmol/L*

4.1 (1.1)

4.4 (1.2)

  1. Numbers are percentages unless otherwise stated.
  2. *Mean (standard deviation).
  3. CVD: cardiovascular disease; HRT: hormone replacement therapy.
  4. TG: triglycerides, TC: total cholesterol, HDL-c: high-density lipoprotein cholesterol, LDL-c: low-density lipoprotein cholesterol.